• FirefoxInstall the new Firefox »
  •  Dow Up0.86% Nasdaq Up0.90%

    Neurocrine Biosciences Inc. (NBIX)

    -NasdaqGS
    40.43 Up 1.38(3.53%) Mar 2, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue -   2,919   53,140  
    Cost of Revenue -   -   -  
    Gross Profit -   2,919   53,140  
    Operating Expenses
    Research Development46,425  39,248  37,163  
    Selling General and Administrative17,986  13,349  14,529  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (64,411) (49,678) 1,448  
    Income from Continuing Operations
    Total Other Income/Expenses Net3,869  3,588  3,577  
    Earnings Before Interest And Taxes(60,542)(46,090)5,025  
    Interest Expense -   -   -  
    Income Before Tax(60,542)(46,090)5,025  
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(60,542)(46,090)5,025  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (60,542) (46,090) 5,025  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (60,542) (46,090) 5,025  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.